Fennec Pharmaceuticals, Inc. (FENC)
11.71
+0.31
(+2.72%)
USD |
NASDAQ |
Aug 25, 16:00
11.74
+0.03
(+0.26%)
After-Hours: 19:59
Fennec Pharmaceuticals Total Assets (Quarterly) : 75.75M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 75.75M |
| March 31, 2026 | 71.82M |
| December 31, 2025 | 70.58M |
| September 30, 2025 | 49.26M |
| June 30, 2025 | 44.88M |
| March 31, 2025 | 46.40M |
| December 31, 2024 | 44.95M |
| September 30, 2024 | 58.92M |
| June 30, 2024 | 63.16M |
| March 31, 2024 | 69.19M |
| December 31, 2023 | 26.86M |
| September 30, 2023 | 19.03M |
| June 30, 2023 | 19.44M |
| March 31, 2023 | 21.82M |
| December 31, 2022 | 26.94M |
| September 30, 2022 | 30.42M |
| June 30, 2022 | 15.57M |
| March 31, 2022 | 19.15M |
| December 31, 2021 | 22.41M |
| September 30, 2021 | 26.01M |
| June 30, 2021 | 28.12M |
| March 31, 2021 | 27.82M |
| December 31, 2020 | 31.42M |
| September 30, 2020 | 34.07M |
| June 30, 2020 | 39.32M |
| Date | Value |
|---|---|
| March 31, 2020 | 10.37M |
| December 31, 2019 | 14.15M |
| September 30, 2019 | 15.91M |
| June 30, 2019 | 17.83M |
| March 31, 2019 | 20.66M |
| December 31, 2018 | 22.95M |
| September 30, 2018 | 24.94M |
| June 30, 2018 | 25.70M |
| March 31, 2018 | 26.84M |
| December 31, 2017 | 28.40M |
| September 30, 2017 | 9.888M |
| June 30, 2017 | 10.26M |
| March 31, 2017 | 3.288M |
| December 31, 2016 | 3.972M |
| September 30, 2016 | 4.58M |
| June 30, 2016 | 5.104M |
| March 31, 2016 | 0.588M |
| December 31, 2015 | 1.019M |
| September 30, 2015 | 1.45M |
| June 30, 2015 | 1.871M |
| March 31, 2015 | 1.949M |
| December 31, 2014 | 2.372M |
| September 30, 2014 | 0.673M |
| June 30, 2014 | 1.049M |
| March 31, 2014 | 1.395M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Abeona Therapeutics, Inc. | 179.51M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 33.31M |
| Shareholders Equity (Quarterly) | 42.44M |
| Current Ratio | 5.850 |
| Net Debt Paydown Yield | 0.96% |